Galderma’s Relfydess™ (RelabotulinumtoxinA) Receives Positive Decision for Use in Europe
资讯
2024-07-30
Ad hoc announcement pursuant to Art. 53 LR
RelfydessTM (RelabotulinumtoxinA) is the first and only ready-to-use liquid neuromodulator created with PEARLTM Technology, developed and manufactured by...